How to vet a GLP-1 telehealth provider
Not a score, not a badge — a checklist. Every check maps to a recorded field, so you can run it across the whole tracked market instead of one checkout page.
As of August 31, 2026:
Before paying any GLP-1 telehealth program, check five things on the provider’s own pages. One: the dispensing pharmacy is named — only 14 of the 59 programs we track name at least one. Two: a prescription and a clinician review are required; anything sold “for research use only” is not being sold for human use and does not appear in our rankings. Three: the recurring price is in writing — not just the first-month price — including any membership fee and the price at the dose you will actually reach after titration. Four: billing frequency and cancellation terms are stated; a “per month” rate billed as a four-figure prepayment is a different purchase. Five: the program publishes a price at all — 10 tracked programs publish none, and we list them at grade U with no number rather than inventing one. Every one of these checks maps to a recorded field in the open dataset, so you can run the checklist over 59 programs at once instead of one checkout page at a time.
1. The dispensing pharmacy is named
Only 14 of the 59 programs we track name at least one dispensing pharmacy on their own pages; the rest state a classification without a name, or nothing. A named pharmacy is checkable against state boards and the FDA’s 503B registry; an unnamed one is a trust-me. The recorded relationships are on the pharmacies page and in /data/pharmacies.json, always labeled provider-stated.
2. A prescription and clinician review are required
Every ranked program in this database sells prescription medication through a clinician workflow. Anything offered without a prescription, or labeled “for research use only”, is not being sold for human use and is outside this database entirely — that disclaimer is the tell, not a technicality.
3. The recurring price is in writing
Three different numbers get advertised as “the price”: a first-month promotion, a starting-dose rate, and the recurring all-in cost. Ask for the third, in writing, including any membership fee and the price at the dose you will reach after titration — 10 of 20 verified tirzepatide providers state flat-dose pricing; at the others the maintenance-dose price is the number that matters and is not always published. Our tables model it where published and say “not published” where not (dose surcharges research).
4. Billing frequency and cancellation are stated
“$125 per month” billed as a $1,500 prepayment is a different purchase from a $169 monthly bill. The row-level fields for billing cycle, upfront payment and commitment are in every table here, and “billing not stated” is recorded rather than assumed (monthly vs prepaid research).
5. There is a published price at all
10 tracked programs publish no purchasable public price. We list them at grade U with no number — and treat any third-party figure for them as grade D — rather than inventing one. A quote-only model is a normal business choice; a specific dollar figure with no source is not a price, it is a rumor.
Run the checklist at scale
All five checks are columns in the open dataset: /data/providers.json and /data/prices.json, CC BY 4.0. The verification process and methodology pages document exactly how each field gets recorded.
Definitions used on this page
Questions this page answers
How do I check whether a GLP-1 telehealth provider is legitimate?
Before paying any GLP-1 telehealth program, check five things on the provider’s own pages. One: the dispensing pharmacy is named — only 14 of the 59 programs we track name at least one. Two: a prescription and a clinician review are required; anything sold “for research use only” is not being sold for human use and does not appear in our rankings. Three: the recurring price is in writing — not just the first-month price — including any membership fee and the price at the dose you will actually reach after titration. Four: billing frequency and cancellation terms are stated; a “per month” rate billed as a four-figure prepayment is a different purchase. Five: the program publishes a price at all — 10 tracked programs publish none, and we list them at grade U with no number rather than inventing one. Every one of these checks maps to a recorded field in the open dataset, so you can run the checklist over 59 programs at once instead of one checkout page at a time.
Are the ultra-cheap tirzepatide prices online real?
Some of them are real prices with strings attached; none of the very lowest is a figure we have verified. The cheapest tirzepatide figures circulating — around $109 per month — come from third-party roundups, and our database carries them at grade D: listed, attributed to the roundup that reported them, and excluded from every verified statistic until our editors record them from the provider’s own page. The cheapest figure we have verified first-party is Trimi at $125 per month on a 12-month plan, billed as a $1,500 prepayment, and the cheapest verified true month-to-month price is NexLife at $169. When a price looks unusually low, check which of three things it is: an annual-prepay rate advertised per month, a starting-dose teaser with the maintenance price unpublished, or a promotional rate with no standing price behind it. All three get advertised as “per month”; none is a month-to-month bill.
Does this site score or certify providers?
No. We publish verified prices, terms and disclosures with sources, dates and grades, and we publish the checklist so you can apply it. Certification businesses and pay-for-badges are exactly the incentive structure this database exists to route around.